Related Experiment Video
Updated: Jun 11, 2026
09:57
Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles
Published on: June 28, 2021
Interleukin-27 acts as multifunctional antitumor agent in multiple myeloma
Claudia Cocco1, Nicola Giuliani, Emma Di Carlo
1Department of Experimental and Laboratory Medicine, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
Summary
Interleukin-27 (IL-27) shows promise as a novel therapy for multiple myeloma (MM). This study found IL-27 inhibits MM cell growth, angiogenesis, and osteoclast activity while promoting osteoblast proliferation.
Area of Science:
- Hematology
- Oncology
- Immunology
- Bone Biology
Background:
- Multiple myeloma (MM) originates from bone marrow plasma cells.
- MM can cause skeletal destruction by disrupting bone remodeling.
- Microenvironmental factors influence MM progression and bone damage.
Purpose of the Study:
- To investigate the potential of interleukin-27 (IL-27) as an antitumor agent in MM.
- To determine IL-27's direct effects on MM cells.
- To assess IL-27's impact on osteoclast and osteoblast activity.
Main Methods:
- Assessed IL-27's effects on MM cell proliferation, apoptosis, angiogenesis, and chemotaxis.
- Evaluated IL-27's influence on osteoclast and osteoblast differentiation and function.
- Conducted in vivo studies using immunodeficient mice and analyzed tumors via immunohistochemistry and PCR array.
Main Results:
- IL-27 significantly inhibited MM cell growth and angiogenesis in primary cells and cell lines.
- IL-27 suppressed osteoclast differentiation and activity.
- IL-27 promoted osteoblast proliferation.
- In vivo studies confirmed IL-27's ability to dampen MM tumor growth by inhibiting angiogenesis.
Conclusions:
- IL-27 demonstrates direct antitumor activity against MM cells.
- IL-27 effectively inhibits osteoclast differentiation and activity.
- IL-27 may serve as a novel therapeutic agent for multiple myeloma, targeting both cancer cells and bone microenvironment.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...